Search
for
Sort by
Research 571–600 of 1000+
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from
- Mechanisms of tolerance and potential therapeutic interventions in Alopecia Areata
- What is behind the ‘swarm of bees’ in alopecia areata
- Women's Skin throughout Lifetime
- The exposome impact on hair health: etiology, pathogenesis and clinical features ‒ Part I
- Subcutaneous Chest Abscess Caused by Candida albicans Infection Following Laparoscopic Cholecystectomy in an Immunocompetent Patient: A Case Report
- A Case of Unilateral Idiopathic Gynecomastia Aggravated by Low-dose Finasteride (1mg/day, Propecia$^{(R)}$)
- Green Surface Engineering of Spun-Bonded Nonwovens Using Polyphenol-Rich Berry Extracts for Bioactive and Functional Applications
- KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target
- Acquired Trichorrhexis Nodosa Caused by Massage of the Scalp After Topical Minoxidil: A Case Report and Review of the Literature
- Сечова кислота в житті чоловіка
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- 612 Wnt signaling induces fibrotic fat loss via DPP4 in skin fibrosis
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
- Pediatric Dermatology Photoquiz: A 14-Year-Old Boy with Abrupt-Onset Hair Changes
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Development of PEGylated Liposomes
- Cutaneous Drug Reaction Case Reports
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- How to Diagnose Hair Loss
- Genetic Tools for Cell Lineage Tracing and Profiling Developmental Trajectories in the Skin
- Application and Prospect of Mesenchymal Stem Cells in the Field of Skin
- Recent advances in oxasteroids chemistry
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Biological Roles and Prospects of using Adipose Tissue Derivatives and Platelet-Rich Plasma in Surgical Practice: A Review
- Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination
- Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride